Article View: be.science
Article #448Cancer - Press Review (December 8, 2012) – Revue de presse (8 décembre 2012)
From: SMW
Date: Sat, 08 Dec 2012 11:11
Date: Sat, 08 Dec 2012 11:11
145 lines
7009 bytes
7009 bytes
Cancer – Press Review – Revue de Presse Every week on http://marclacroixcancerblog.blogspot.com Chaque semaine sur http://marclacroixcancerblog.blogspot.com Press Review (December 8, 2012) – Revue de presse (8 décembre 2012) Extended Use of Breast Cancer Drug Is Suggested The widely prescribed drug tamoxifen already plays a major role in reducing the risk of death from breast cancer. But a new study suggests that women should be taking the drug for twice as long as is now customary, a finding that could upend the standard that has been in place for about 15 years. By Andrew Pollack. In The New York Times http://www.nytimes.com/2012/12/06/health/extended-use-of-breast-cancer-drug-suggested.html?_r=0 Is a Breath Test for Colon Cancer Possible? In small study, Italian researchers detected who had the disease with 75 percent accuracy. By Amy Norton. In U.S. News & World Report http://health.usnews.com/health-news/news/articles/2012/11/30/obesity-complicates-lung-cancer-surgery-study Cancer Genome Consortium Expands China Research The International Cancer Genome Consortium is expanding its research in China, where new projects seeking genomic factors in four cancer types common to the world’s most populous nation will be launched. In Genetic Engineering News http://www.genengnews.com/gen-news-highlights/cancer-genome-consortium-expands-china-research/81247724/ Childhood Cancer-Linked Mutations May Point Toward New Targets The discovery of mutations in two related genes that are involved in neuroblastoma, the most aggressive form of childhood cancer, may identify a novel, defective pathway in these cancers and help uncover potential new therapeutic targets. In Genetic Engineering News http://www.genengnews.com/gen-news-highlights/childhood-cancer-linked-mutations-may-point-toward-new-targets/81247711/ Cancer and Foggy Thinking: Is Chemotherapy Really the Cause? Women who receive chemotherapy to treat breast cancer have long reported confusion, disorganization, difficulty concentrating and problems recalling conversations following therapy By Alice Park. In TIME http://healthland.time.com/2012/12/07/cancer-and-foggy-thinking-is-chemotherapy-really-the-cause/ Aspirin may help older colon cancer patients live longer Older adults with colon cancer who were prescribed a daily aspirin were less likely to die than those who weren't, according to a new study. By Katherine Hobson. In Reuters http://www.reuters.com/article/2012/12/07/us-aspirin-coloncancer-idUSBRE8B60OV20121207 Existing drugs may help more breast cancer patients More patients can benefit from highly effective breast cancer drugs that are already available, according to DNA sequencing studies by researchers at Washington University School of Medicine in St. Louis and other institutions. The investigators found that some women with the HER2 negative subtype may benefit from anti-HER2 drugs even though standard tests don't indicate they are candidates for the drugs. In EurekAlert (press release) http://www.eurekalert.org/pub_releases/2012-12/wuso-edm120512.php Cancer : les inégalités sociales se creusent Les personnes issues des catégories socioprofessionnelles les moins favorisées souffrent et meurent plus du cancer que les autres. Par Anne Jeanblanc. Dans Le Point http://www.lepoint.fr/chroniqueurs-du-point/anne-jeanblanc/cancer-les-inegalites-sociales-se-creusent-03-12-2012-1537959_57.php La metformine pour traiter le cancer de l'ovaire La metformine permettrait à des patientes atteintes du cancer de l'ovaire d'augmenter leur durée de vie. Sur Canoë http://fr.canoe.ca/sante/archives/2012/12/20121203-140756.html Création d'un pôle parisien sur le cancer Un pôle public de recherche et lutte contre le cancer, l'Institut universitaire de cancérologie (IUC), a été créé cette semaine pour unir "de manière innovante" différents acteurs parisiens dans ce domaine, a annoncé aujourd'hui son directeur, Serge Uzan. Dans Le Figaro http://www.lefigaro.fr/flash-actu/2012/11/30/97001-20121130FILWWW00536-creation-d-un-pole-parisien-sur-le-cancer.php Hollande annonce un 3e Plan cancer axé sur la lutte contre les inégalités Le président François Hollande a annoncé mardi à Paris un troisième Plan cancer sur quatre ans (2014-2018) axé sur la lutte contre les inégalités face à la maladie et préparer la France "aux nouveaux enjeux liés aux progrès médicaux". Dans Le Point http://www.lepoint.fr/politique/hollande-annonce-un-3e-plan-cancer-axe-sur-la-lutte-contre-les-inegalites-04-12-2012-1539363_20.php Un médicament du cancer du sein pourrait permettre de lutter contre d'autres tumeurs Une nouvelle recherche du Royaume-Uni montre qu'un médicament utilisé contre le cancer du sein pourrait être utilisé contre d'autres tumeurs. Le médicament en question est le geldanamycin, connu pour sa capacité d'attaquer une protéine associée à la progression du cancer du sein. Plus récemment, une étude en laboratoire a découvert qu'il peut dégrader une autre protéine qui entraîne l'angiogenèse. Ces résultats ont été publiés dans la revue PLoS ONE. Dans Cordis actualités http://cordis.europa.eu/fetch?CALLER=FR_NEWS&ACTION=D&SESSION=&RCN=35311 Cancer Blog – Marc Lacroix – Le Blogue du Cancer http://marclacroixcancerblog.blogspot.com Marc Lacroix-Corman – InTextoResearch – Baelen (12/2012)
Technical Details
Message-ID:
<53b11bbe-9439-4f19-83fe-0f914ac50816@eo2g2000vbb.googlegroups.com>Path:
arc1-ca.pugleaf.net!gf5ni48613681qab.0!nntp.google.com!c8no2043558qao.0!postnews.google.com!eo2g2000vbb.googlegroups.com!not-for-mailShow Full Headers
Complete Article Headers
X-Google-Thread: a254ea4a8d,4a77b77bb51db41d,start
X-Google-Attributes: gida254ea4a8d,public,usenet
X-Google-NewGroupId: yes
X-Google-Language: ENGLISH,CP1252
Received: by 10.224.189.16 with SMTP id dc16mr6564297qab.0.1354965078165;
Sat, 08 Dec 2012 03:11:18 -0800 (PST)
MIME-Version: 1.0
Received: by 10.49.72.169 with SMTP id e9mr2026959qev.3.1354965078126; Sat, 08
Dec 2012 03:11:18 -0800 (PST)
Path: arc1-ca.pugleaf.net!gf5ni48613681qab.0!nntp.google.com!c8no2043558qao.0!postnews.google.com!eo2g2000vbb.googlegroups.com!not-for-mail
Newsgroups: be.science
Date: Sat, 8 Dec 2012 03:11:18 -0800 (PST)
Complaints-To: groups-abuse@google.com
Injection-Info: eo2g2000vbb.googlegroups.com; posting-host=81.247.156.66; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE
NNTP-Posting-Host: 81.247.156.66
User-Agent: G2/1.0
X-HTTP-UserAgent: Mozilla/5.0 (Windows NT 5.1) AppleWebKit/537.11 (KHTML, like
Gecko) Chrome/23.0.1271.95 Safari/537.11,gzip(gfe)
Message-ID: <53b11bbe-9439-4f19-83fe-0f914ac50816@eo2g2000vbb.googlegroups.com>
Subject: Cancer - Press Review (December 8, 2012) – Revue de presse (8 décembre 2012)
From: SMW <scimedweb@mail.com>
Injection-Date: Sat, 08 Dec 2012 11:11:18 +0000
Content-Type: text/plain; charset=windows-1252
Content-Transfer-Encoding: quoted-printable